←Back to Expert Scholars
Translational Medicine / 转化医学Chondrosarcoma, Chordoma
Silvia Stacchiotti
MD
🏢Fondazione IRCCS Istituto Nazionale dei Tumori Milan🌐Italy
Head, Adult Mesenchymal and Rare Tumor Medical Oncology
70
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Silvia Stacchiotti has led international efforts in chondrosarcoma and chordoma including clinical trial design for ultra rare tumors. She has contributed to IDH inhibitor studies in IDH mutant chondrosarcoma. Her group shapes ESMO rare cancer guidelines.
Share:
🧪Research Fields 研究领域
chondrosarcoma
chordoma
rare sarcoma
IDH inhibitors
European trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Silvia Stacchiotti 的研究动态
Follow Silvia Stacchiotti's research updates
留下邮箱，当我们发布与 Silvia Stacchiotti（Fondazione IRCCS Istituto Nazionale dei Tumori Milan）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment